Similar to our findings in subcutaneous models, EV tumors showed robust tumor regressions, whereas Zeb1/Snail OE tumors exhibited delayed but progressive growth following immunotherapy (Fig. 2j–l). The gene discussed is ZEB1; the disease is neoplasm.